The CheckMate 8HW trial evaluated the efficacy of nivolumab–ipilimumab versus nivolumab monotherapy in patients with microsatellite instability-high or mismatch repair-deficient metastatic colorectal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback